Michael Schmiech
Impact in
- Drug Discovery top 10%
- Pharmacology top 10%
- Pharmacological Effects of Medicinal Plants
Papers in
-
- Pharmacological Effects of Medicinal Plants 8
-
- Phytochemistry and Bioactive Compounds 3
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Thomas Simmet (20 shared papers)Tatiana Syrovets (19 shared papers)Menna El Gaafary (10 shared papers)Sophia J. Lang (6 shared papers)Susanne Häfner (7 shared papers)Christian Paetz (4 shared papers)Christoph Q. Schmidt (4 shared papers)Carmen Steinborn (2 shared papers)
In The Last Decade
Michael Schmiech
21 papers receiving 481 citations
Peers
Comparison fields: 5 of 60
- Drug Discovery 6
- Pharmacology 120
- Cancer Research 45
- Complementary and alternative medicine 29
- Biomaterials 29
Countries citing papers authored by Michael Schmiech
This map shows the geographic impact of Michael Schmiech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schmiech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schmiech more than expected).
Fields of papers citing papers by Michael Schmiech
This network shows the impact of papers produced by Michael Schmiech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schmiech. The network helps show where Michael Schmiech may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Schmiech, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 94 | |
| 2 | 2019 | 60 | |
| 3 | 2020 | 43 | |
| 4 | 2019 | 40 | |
| 5 | 2020 | 40 | |
| 6 | 2021 | 39 | |
| 7 | 2019 | 35 | |
| 8 | 2017 | 30 | |
| 9 | 2016 | 23 | |
| 10 | 2017 | 22 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 9 | |
| 15 | 2019 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2024 | 4 | |
| 18 | 2017 | 2 | |
| 19 | 2017 | 1 | |
| 20 | 2019 | 1 |
About Michael Schmiech
Michael Schmiech is a scholar working on Pharmacology, Biomaterials, Cancer Research, Molecular Biology and Toxicology, having authored 23 papers that have together received 492 indexed citations. Recurring topics across this work include Pharmacological Effects of Medicinal Plants (8 papers), Sesquiterpenes and Asteraceae Studies (4 papers), Phytochemistry and Bioactive Compounds (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Medicinal Plant Research (2 papers), Phytochemistry and Biological Activities (1 paper), Folate and B Vitamins Research (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Drug Discovery (6 citations), Pharmacology (120 citations), Cancer Research (45 citations), Complementary and alternative medicine (29 citations) and Biomaterials (29 citations). Michael Schmiech has collaborated with scholars based in Germany, Egypt and Libya. Frequent co-authors include Thomas Simmet, Tatiana Syrovets, Menna El Gaafary, Sophia J. Lang, Susanne Häfner, Christian Paetz, Christoph Q. Schmidt, Carmen Steinborn, Roman Huber and Luay J. Rashan. Their work appears in journals such as The FASEB Journal, Phytomedicine, Molecules, Frontiers in Immunology and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.